Smoking confounds the periodontal diagnostics using saliva biomarkers.


Journal

Journal of periodontology
ISSN: 1943-3670
Titre abrégé: J Periodontol
Pays: United States
ID NLM: 8000345

Informations de publication

Date de publication:
05 2019
Historique:
received: 17 09 2018
revised: 06 11 2018
accepted: 06 11 2018
pubmed: 18 11 2018
medline: 18 12 2019
entrez: 18 11 2018
Statut: ppublish

Résumé

Smoking is a risk factor for periodontal disease because of its complex impact on the inflammatory response in the periodontium. We investigated the effect of smoking on salivary periodontal biomarkers, matrix metalloproteinase (MMP)-8, MMP-9, tissue inhibitor of metalloproteinase (TIMP)-1 and myeloperoxidase (MPO). Saliva biomarkers were analyzed in the Parogene population (n = 480) comprising a random cohort of patients that have undergone coronary angiography and oral examination. The effect of time since cessation and pack years of smoking on biomarkers were investigated. Saliva MMP-8, MMP-9, TIMP-1, and MPO concentrations distinguished periodontitis patients significantly from patients without periodontitis. When the time since cessation was considered, the area-under-the-curve values (p-value) for periodontitis were 0.76 (<0.001), 0.74 (<0.001), 0.70 (<0.001), and 0.76 (<0.001), respectively. Adding information about smoking habits in the models improved slightly the sensitivities of all biomarkers. In logistic regression model saliva, MMP-8 was mainly affected by pack years of smoking, whereas saliva MMP-9, TIMP-1, and MPO were mostly affected by time since cessation, especially if smoking currently or quit recently (<1 year ago). Smoking confounds the salivary diagnostics of periodontitis and should be considered when interpreting the results obtained by potential diagnostic tests.

Sections du résumé

BACKGROUND
Smoking is a risk factor for periodontal disease because of its complex impact on the inflammatory response in the periodontium. We investigated the effect of smoking on salivary periodontal biomarkers, matrix metalloproteinase (MMP)-8, MMP-9, tissue inhibitor of metalloproteinase (TIMP)-1 and myeloperoxidase (MPO).
METHODS
Saliva biomarkers were analyzed in the Parogene population (n = 480) comprising a random cohort of patients that have undergone coronary angiography and oral examination. The effect of time since cessation and pack years of smoking on biomarkers were investigated.
RESULTS
Saliva MMP-8, MMP-9, TIMP-1, and MPO concentrations distinguished periodontitis patients significantly from patients without periodontitis. When the time since cessation was considered, the area-under-the-curve values (p-value) for periodontitis were 0.76 (<0.001), 0.74 (<0.001), 0.70 (<0.001), and 0.76 (<0.001), respectively. Adding information about smoking habits in the models improved slightly the sensitivities of all biomarkers. In logistic regression model saliva, MMP-8 was mainly affected by pack years of smoking, whereas saliva MMP-9, TIMP-1, and MPO were mostly affected by time since cessation, especially if smoking currently or quit recently (<1 year ago).
CONCLUSION
Smoking confounds the salivary diagnostics of periodontitis and should be considered when interpreting the results obtained by potential diagnostic tests.

Identifiants

pubmed: 30447005
doi: 10.1002/JPER.18-0545
doi:

Substances chimiques

Biomarkers 0
Tissue Inhibitor of Metalloproteinase-1 0
Matrix Metalloproteinase 8 EC 3.4.24.34

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

475-483

Informations de copyright

© 2018 American Academy of Periodontology.

Auteurs

Laura Lahdentausta (L)

Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Finland.

Susanna Paju (S)

Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Finland.

Päivi Mäntylä (P)

Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Finland.
Institute of Dentistry, University of Eastern Finland, Kuopio, Finland.
Kuopio University Hospital, Oral and Maxillofacial Diseases, Kuopio, Finland.

Kåre Buhlin (K)

Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Finland.
Division of Periodontology, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.

Milla Pietiäinen (M)

Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Finland.

Taina Tervahartiala (T)

Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Finland.

Markku S Nieminen (MS)

HUCH Heart and Lung Center, Helsinki University Central Hospital, Helsinki, Finland.

Juha Sinisalo (J)

HUCH Heart and Lung Center, Helsinki University Central Hospital, Helsinki, Finland.

Timo Sorsa (T)

Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Finland.
Division of Periodontology, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.

Pirkko J Pussinen (PJ)

Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH